|CN-Healthcare||Beijing, China, Haidian|
|Dorset Capital Management||California, San Francisco, United States|
|ETFS Capital||England, London, United Kingdom|
|First Rays Venture Partners||California, San Francisco, United States|
|Flat6Labs Tunis||Gabès, Tunis, Tunisia|
|Gaydoul Group||Pfaffikon, Switzerland, Zurich|
|Hearst Health Ventures||New York, New York, United States|
|IdeaLab Capital Partners||California, Pasadena, United States|
|Liberty Media||Colorado, Englewood, United States|
|Method Capital||Chicago, Illinois, United States|
|OSS Capital, L.P.||California, San Francisco, United States|
|Paxion Capital Partners||California, Menlo Park, United States|
|Rader Reinfrank Investors||Beverly Hills, California, United States|
|Synergy Marketing||Japan, Osaka, Osaka Prefecture|
|ThedaCare||Appleton, United States, Wisconsin|
|tokentus investment AG||Frankfurt, Germany, Hessen|
|$63M||04 Mar 2020||San Francisco, California, United States|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.